Repro Med Systems, Inc. (KRMD): Price and Financial Metrics
KRMD Price/Volume Stats
| Current price | $2.74 | 52-week high | $4.48 |
| Prev. close | $2.79 | 52-week low | $2.13 |
| Day low | $2.69 | Volume | 24,900 |
| Day high | $2.83 | Avg. volume | 85,137 |
| 50-day MA | $2.65 | Dividend yield | N/A |
| 200-day MA | $3.53 | Market Cap | 125.05M |
KRMD Stock Price Chart Interactive Chart >
KRMD POWR Grades
- KRMD scores best on the Sentiment dimension, with a Sentiment rank ahead of 78.54% of US stocks.
- The strongest trend for KRMD is in Value, which has been heading up over the past 158 days.
- KRMD ranks lowest in Momentum; there it ranks in the 5th percentile.
KRMD Stock Summary
- The ratio of debt to operating expenses for KORU MEDICAL SYSTEMS INC is higher than it is for about just 18.61% of US stocks.
- With a price/sales ratio of 4.34, KORU MEDICAL SYSTEMS INC has a higher such ratio than 77.12% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.31 for KORU MEDICAL SYSTEMS INC; that's greater than it is for only 17.53% of US stocks.
- Stocks that are quantitatively similar to KRMD, based on their financial statements, market capitalization, and price volatility, are AMSC, SONX, NVVE, AXGN, and VRNT.
- KRMD's SEC filings can be seen here. And to visit KORU MEDICAL SYSTEMS INC's official web site, go to www.korumedical.com.
KRMD Valuation Summary
- KRMD's EV/EBIT ratio is -11.9; this is 202.59% lower than that of the median Healthcare stock.
- KRMD's price/sales ratio has moved up 3.8 over the prior 243 months.
Below are key valuation metrics over time for KRMD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| KRMD | 2023-09-22 | 4.3 | 4.5 | -15.8 | -11.9 |
| KRMD | 2023-09-21 | 4.5 | 4.7 | -16.4 | -12.4 |
| KRMD | 2023-09-20 | 4.8 | 5.0 | -17.3 | -13.2 |
| KRMD | 2023-09-19 | 4.4 | 4.6 | -15.9 | -12.0 |
| KRMD | 2023-09-18 | 4.1 | 4.3 | -15.0 | -11.3 |
| KRMD | 2023-09-15 | 4.1 | 4.3 | -15.0 | -11.3 |
KRMD Growth Metrics
- Its 2 year cash and equivalents growth rate is now at 203.96%.
- Its 3 year cash and equivalents growth rate is now at 448.35%.
- Its 3 year price growth rate is now at 74.56%.
The table below shows KRMD's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 27.04186 | -7.458145 | -7.752773 |
| 2022-06-30 | 25.32201 | -6.168674 | -7.620991 |
| 2022-03-31 | 24.30355 | -3.465929 | -5.824199 |
| 2021-12-31 | 23.49018 | -4.31951 | -4.562823 |
| 2021-09-30 | 21.05689 | -5.314138 | -4.329093 |
| 2021-06-30 | 21.09666 | -6.227022 | -2.98614 |
KRMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- KRMD has a Quality Grade of D, ranking ahead of 19.43% of graded US stocks.
- KRMD's asset turnover comes in at 0.501 -- ranking 94th of 186 Medical Equipment stocks.
- CSII, NVRO, and XENT are the stocks whose asset turnover ratios are most correlated with KRMD.
The table below shows KRMD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.501 | 0.601 | -0.483 |
| 2021-03-31 | 0.531 | 0.618 | -0.535 |
| 2020-12-31 | 0.646 | 0.618 | -0.188 |
| 2020-09-30 | 0.852 | 0.630 | -0.036 |
| 2020-06-30 | 1.170 | 0.634 | 0.047 |
| 2020-03-31 | 1.753 | 0.636 | 0.245 |
KRMD Price Target
For more insight on analysts targets of KRMD, see our KRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $5.17 | Average Broker Recommendation | 1.83 (Hold) |
Repro Med Systems, Inc. (KRMD) Company Bio
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
Latest KRMD News From Around the Web
Below are the latest news stories about KORU MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate KRMD as an investment opportunity.
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company ShowcaseMAHWAH, N.J., September 15, 2023--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase on September 21, 2023. |
KORU Medical Systems, Inc. (NASDAQ:KRMD) has caught the attention of institutional investors who hold a sizeable 34% stakeKey Insights Significantly high institutional ownership implies KORU Medical Systems' stock price is sensitive to their... |
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 OutlookMAHWAH, N.J., August 09, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the second quarter ended June 30, 2023 and updates full year 2023 outlook. |
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth ConferenceMAHWAH, N.J., August 08, 2023--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023. |
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive UpdatesMAHWAH, N.J., August 02, 2023--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced preliminary unaudited revenues for the second quarter 2023 and provided business, outlook and executive updates. |
KRMD Price Returns
| 1-mo | 5.79% |
| 3-mo | -21.04% |
| 6-mo | -34.68% |
| 1-year | 19.65% |
| 3-year | -60.97% |
| 5-year | 92.96% |
| YTD | -23.25% |
| 2022 | 19.00% |
| 2021 | -50.17% |
| 2020 | -7.81% |
| 2019 | 295.76% |
| 2018 | 32.00% |
Loading social stream, please wait...